Pioneering game-changing endovascular therapy technologies and devices
According to the World Stroke Organization, over 13 million people suffer from strokes every year and over 40% die as a result of them. With both numbers rising unless necessary actions are taken, the team at Merlin are determined to do their part.
Merlin’s first flow-Diverter device, the XCalibur Aneurysm Occlusion Device (AOD), was introduced to the wider market in 2015. The underlying polymer-membrane technology aims to treat and prevent the rupture of cerebral aneurysms in a unique and effective manner. At the same time, Merlin’s team of engineers, innovators and advisors, are developing devices to treat ischemic strokes and address the pharmacotherapy requirements of endovascular implants.
A key player in medical devices, Merlin Medical is redefining the endovascular treatment of strokes to meet the ever-changing landscape of today and tomorrow.
OUR MISSION & VISION
Mission
To develop the most innovative and trusted technologies and devices for endovascular therapy.
Vision
To offer the world’s best complete stroke care solution.
OUR CLINICAL & SCIENTIFIC ADVISORY BOARD
OUR CLINICAL & SCIENTIFIC ADVISORY BOARD
-
Dr. Christophe CognardDr. Cognard has been the Chairman of the Department of Diagnostics and Therapeutic Neuroradiology at the Hospital of Purpan and Hospital of Rangueil since December 2002. He is also the Professor of Radiology at the University of Toulouse since September 1999 and was an invited professor at the University of Montreal in 2008. Previously, Dr. Cognard consulted the Department of Neuroradiology at the Rothschild Ophthalmological Foundation and has been the President of the Annual Congress of the French Society of Neuroradiology (SFNR). He was also President and General Secretary of the Annual ESMINT Congress from 2009 to 2014. Dr. Cognard has over 150 publications in scientific journals, 22 didactic articles and 6 book chapters.
-
Dr Nobuyuki SakaiDr. Sakai is the Director of Neurosurgery at the Kobe City Medical Center General Hospital and the Director of Neuroendovascular Therapy at the Institute of Biomedical Research and Innovation. One of the most clinically experienced neurosurgeons in Japan, Dr. Sakai has performed thousands of catheter-assisted neuroendovascular procedures, including 2,000 cerebral aneurysm embolization, 350 cerebral arteriovenous malformation embolization, 400 dural arteriovenous fistula embolization and 1,200 carotid artery stent replacement procedures. He has also done over 1,000 craniotomy & cerebral aneurysm clips. Dr. Sakai also serves on the board of or as advisor to 15 medical societies including the Japan Neurosurgical Society and the Japanese Congress of Neurological Surgeons.
-
Dr. Alejandro Tomasello WeitzDr. Alejandro Tomasello Weitz is the Head of the Neurointerventional Department at the Hospital Universitari de la Vall d’Hebron, Barcelona, Spain. Dr. Tomasello has published nearly 50 medical articles, collaborated on six published books and is a consultant or advisory board member of Anaconda Biomed, Boston Scientific, Balt, Medtronic, Perflow, Microvention and Stryker.
-
Dr. Santosh JosephDr. Joseph’s career as Interventional Radiologist at MGM Healthcare in Chennai, India spans over three decades. A well-respected member of the medical community, Dr. Joseph is a life member of Indian Radiological and Imaging Association (IR&IA) and Indian Medical Association (IMA), founding member of Indian Society of Vascular and Interventional Radiology (ISVIR), Indian Society of Neuroradiology (ISNR), and member of Neurological Society of India, SRMC, SCTIMST and JIPMER.
-
Dhiren Singh Managing Director and CEODhiren has over 15 years of asset and fund management experience and has served as strategic advisor to various startups in the applied technology, healthcare, engineering and education sectors. He started his career as an engineer manufacturing electric locomotives before pivoting towards financial engineering with high-risk high-yield assets. Dhiren holds an MBA from the Asian Institute of Management and Stockholm School of Economics, Bachelor of Electrical Engineering degree and the Chartered Alternate Investment Analyst (CAIA).